Open AccessPre-Emptive Donor-Derived Innate Immune Cell Add-Back after Haploidentical Hematopoietic Stem Cell Transplantation to Reduce High Rate of Infection, Gvhd, and Non-Relapse Mortality
Author(s) -
Noah Merin,
Tu Nguyen,
Jonathan Kaye,
Ronald Paquette,
Robert Vescio,
Akil Merchant
Publication year - 2020
Publication title -
biology of blood and marrow transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.301
H-Index - 120
eISSN - 1523-6536
pISSN - 1083-8791
DOI - 10.1016/j.bbmt.2019.12.443
Subject(s) - medicine , fludarabine , donor lymphocyte infusion , bendamustine , transplantation , regimen , rituximab , hematopoietic stem cell transplantation , oncology , graft versus host disease , immunology , cyclophosphamide , lymphoma , chemotherapy
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom